Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
03-04

DJ Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. $(TECH)$ shed 1.75% to $60.12 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.22% to 5,778.15 and Dow Jones Industrial Average falling 1.55% to 42,520.99.

This was the stock's second consecutive day of losses.

Bio-Techne Corp. closed 29.74% short of its 52-week high of $85.57, which the company achieved on May 15th.

The stock underperformed when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ rose 0.45% to $312.19, Charles River Laboratories International Inc. $(CRL)$ rose 0.50% to $164.31, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.72% to $70.51.

Trading volume (2.0 M) eclipsed its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 04, 2025 17:18 ET (22:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”